94 related articles for article (PubMed ID: 1810412)
1. Lipophilic N-acylpyrazinamide derivatives: synthesis, physicochemical characterization, liposome incorporation, and in vitro activity against Mycobacterium avium-intracellulare.
Liu ZZ; Guo XD; Straub LE; Erdos G; Prankerd RJ; Gonzalez-Rothi RJ; Schreier H
Drug Des Discov; 1991 Nov; 8(1):57-67. PubMed ID: 1810412
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and antimycobacterial activity of pyrazine and quinoxaline derivatives.
Seitz LE; Suling WJ; Reynolds RC
J Med Chem; 2002 Dec; 45(25):5604-6. PubMed ID: 12459027
[TBL] [Abstract][Full Text] [Related]
3. N1-Hetaryl substituted pyridine- and pyrazinecarboxamidrazones with antimycobacterial activity.
Ranft D; Lehwark-Yvetot G; Schaper KJ; Büge A
Arch Pharm (Weinheim); 1997 Jun; 330(6):169-72. PubMed ID: 9297448
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and antimycobacterial evaluation of N-substituted 5-chloropyrazine-2-carboxamides.
Servusová B; Vobicková J; Paterová P; Kubíček V; Kuneš J; Doležal M; Zitko J
Bioorg Med Chem Lett; 2013 Jun; 23(12):3589-91. PubMed ID: 23659859
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, antimycobacterial and antifungal evaluation of some new 1-ethyl-5-(hetero)aryl-6-styryl-1,6-dihydropyrazine-2,3-dicarbonitriles.
Verbitskiy EV; Slepukhin PA; Kravchenko MA; Skornyakov SN; Evstigneeva NP; Kungurov NV; Zil'berberg NV; Rusinov GL; Chupakhin ON; Charushin VN
Bioorg Med Chem Lett; 2015 Feb; 25(3):524-8. PubMed ID: 25556103
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, antimycobacterial and antifungal evaluation of 3-arylaminopyrazine-2,5-dicarbonitriles.
Palek L; Dvorák J; Svobodová M; Buchta V; Jampílek J; Dolezal M
Arch Pharm (Weinheim); 2008 Jan; 341(1):61-5. PubMed ID: 18072243
[TBL] [Abstract][Full Text] [Related]
7. Quantitative structure-activity relationships for the in vitro antimycobacterial activity of pyrazinoic acid esters.
Bergmann KE; Cynamon MH; Welch JT
J Med Chem; 1996 Aug; 39(17):3394-400. PubMed ID: 8765523
[TBL] [Abstract][Full Text] [Related]
8. Substituted N-Phenylpyrazine-2-carboxamides: synthesis and antimycobacterial evaluation.
Dolezal M; Zitko J; Kesetovicová D; Kunes J; Svobodová M
Molecules; 2009 Oct; 14(10):4180-9. PubMed ID: 19924056
[TBL] [Abstract][Full Text] [Related]
9. [In vitro antimycobacterial activities of pyrazinamide analogs: results of screening tests].
Yamamoto S; Toida I; Watanabe N; Ura T
Kekkaku; 1996 Mar; 71(3):253-8. PubMed ID: 8901227
[TBL] [Abstract][Full Text] [Related]
10. In vitro activities of free and liposomal drugs against Mycobacterium avium-M. intracellulare complex and M. tuberculosis.
Mehta RT; Keyhani A; McQueen TJ; Rosenbaum B; Rolston KV; Tarrand JJ
Antimicrob Agents Chemother; 1993 Dec; 37(12):2584-7. PubMed ID: 8109920
[TBL] [Abstract][Full Text] [Related]
11. In vitro antimycobacterial activities of pyrazinamide analogs.
Yamamoto S; Toida I; Watanabe N; Ura T
Antimicrob Agents Chemother; 1995 Sep; 39(9):2088-91. PubMed ID: 8540721
[TBL] [Abstract][Full Text] [Related]
12. Activity of capuramycin analogues against Mycobacterium tuberculosis, Mycobacterium avium and Mycobacterium intracellulare in vitro and in vivo.
Koga T; Fukuoka T; Doi N; Harasaki T; Inoue H; Hotoda H; Kakuta M; Muramatsu Y; Yamamura N; Hoshi M; Hirota T
J Antimicrob Chemother; 2004 Oct; 54(4):755-60. PubMed ID: 15347635
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and antimycobacterial evaluation of N-substituted 3-aminopyrazine-2,5-dicarbonitriles.
Zitko J; Jampílek J; Dobrovolný L; Svobodová M; Kuneš J; Doležal M
Bioorg Med Chem Lett; 2012 Feb; 22(4):1598-601. PubMed ID: 22281187
[TBL] [Abstract][Full Text] [Related]
14. Antimycobacterial activity of a series of pyrazinoic acid esters.
Cynamon MH; Klemens SP; Chou TS; Gimi RH; Welch JT
J Med Chem; 1992 Apr; 35(7):1212-5. PubMed ID: 1560435
[TBL] [Abstract][Full Text] [Related]
15. [Preclinical study of therapeutic agents used against Mycobacterium avium complex infections--with special reference to new macrolides and new quinolones].
Tomioka H; Sato K; Saito H
Kekkaku; 1996 Sep; 71(9):531-5. PubMed ID: 8999135
[No Abstract] [Full Text] [Related]
16. Synthesis and antimycobacterial evaluation of 5-alkylamino-N-phenylpyrazine-2-carboxamides.
Zitko J; Servusová B; Janoutová A; Paterová P; Mandíková J; Garaj V; Vejsová M; Marek J; Doležal M
Bioorg Med Chem; 2015 Jan; 23(1):174-83. PubMed ID: 25438883
[TBL] [Abstract][Full Text] [Related]
17. New series of isoniazid hydrazones linked with electron-withdrawing substituents.
Vavříková E; Polanc S; Kočevar M; Košmrlj J; Horváti K; Bosze S; Stolaříková J; Imramovský A; Vinšová J
Eur J Med Chem; 2011 Dec; 46(12):5902-9. PubMed ID: 22018878
[TBL] [Abstract][Full Text] [Related]
18. Ureidopyrazine Derivatives: Synthesis and Biological Evaluation as Anti-Infectives and Abiotic Elicitors.
Bouz G; Juhás M; Niklová P; Janďourek O; Paterová P; Janoušek J; Tůmová L; Kovalíková Z; Kastner P; Doležal M; Zitko J
Molecules; 2017 Oct; 22(10):. PubMed ID: 29065539
[TBL] [Abstract][Full Text] [Related]
19. Alkylamino derivatives of pyrazinamide: synthesis and antimycobacterial evaluation.
Servusová B; Paterová P; Mandíková J; Kubíček V; Kučera R; Kuneš J; Doležal M; Zitko J
Bioorg Med Chem Lett; 2014 Jan; 24(2):450-3. PubMed ID: 24388809
[TBL] [Abstract][Full Text] [Related]
20. A new modification of anti-tubercular active molecules.
Imramovský A; Polanc S; Vinsová J; Kocevar M; Jampílek J; Recková Z; Kaustová J
Bioorg Med Chem; 2007 Apr; 15(7):2551-9. PubMed ID: 17306980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
